BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 24565854)

  • 21. Survival in patients with clear cell renal cell carcinoma is predicted by HIF-1α expression.
    Minardi D; Lucarini G; Santoni M; Mazzucchelli R; Burattini L; Conti A; Principi E; Bianconi M; Scartozzi M; Milanese G; Di Primio R; Montironi R; Cascinu S; Muzzonigro G
    Anticancer Res; 2015 Jan; 35(1):433-8. PubMed ID: 25550584
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinicopathologic and molecular correlations of necrosis in the primary tumor of patients with renal cell carcinoma.
    Lam JS; Shvarts O; Said JW; Pantuck AJ; Seligson DB; Aldridge ME; Bui MH; Liu X; Horvath S; Figlin RA; Belldegrun AS
    Cancer; 2005 Jun; 103(12):2517-25. PubMed ID: 15880379
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Follistatin-like protein 1 plays a tumor suppressor role in clear-cell renal cell carcinoma.
    Liu Y; Tan X; Liu W; Chen X; Hou X; Shen D; Ding Y; Yin J; Wang L; Zhang H; Yu Y; Hou J; Thompson TC; Cao G
    Chin J Cancer; 2018 Jan; 37(1):2. PubMed ID: 29357946
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of hypoxia-inducible factors 1alpha and 2alpha with activated angiogenic pathways and prognosis in patients with endometrial carcinoma.
    Sivridis E; Giatromanolaki A; Gatter KC; Harris AL; Koukourakis MI;
    Cancer; 2002 Sep; 95(5):1055-63. PubMed ID: 12209691
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of hypoxia inducible factor-1alpha and 2alpha in genetically distinct early renal cortical tumors.
    Kim CM; Vocke C; Torres-Cabala C; Yang Y; Schmidt L; Walther M; Linehan WM
    J Urol; 2006 May; 175(5):1908-14. PubMed ID: 16600797
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor infiltrating mast cells determine oncogenic HIF-2α-conferred immune evasion in clear cell renal cell carcinoma.
    Xiong Y; Liu L; Xia Y; Qi Y; Chen Y; Chen L; Zhang P; Kong Y; Qu Y; Wang Z; Lin Z; Chen X; Xiang Z; Wang J; Bai Q; Zhang W; Yang Y; Guo J; Xu J
    Cancer Immunol Immunother; 2019 May; 68(5):731-741. PubMed ID: 30758643
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression and significance of FOXP1, HIF-1a and VEGF in renal clear cell carcinoma.
    Wan L; Huang J; Chen J; Wang R; Dong C; Lu S; Wu X
    J BUON; 2015; 20(1):188-95. PubMed ID: 25778315
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glucose transporter-1 expression in renal cell carcinoma and its correlation with hypoxia inducible factor-1 alpha.
    Lidgren A; Bergh A; Grankvist K; Rasmuson T; Ljungberg B
    BJU Int; 2008 Feb; 101(4):480-4. PubMed ID: 17922867
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Macrophage HIF-1α Is an Independent Prognostic Indicator in Kidney Cancer.
    Cowman SJ; Fuja DG; Liu XD; Tidwell RSS; Kandula N; Sirohi D; Agarwal AM; Emerson LL; Tripp SR; Mohlman JS; Stonhill M; Garcia G; Conley CJ; Olalde AA; Sargis T; Ramirez-Torres A; Karam JA; Wood CG; Sircar K; Tamboli P; Boucher K; Maughan B; Spike BT; Ho TH; Agarwal N; Jonasch E; Koh MY
    Clin Cancer Res; 2020 Sep; 26(18):4970-4982. PubMed ID: 32586940
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic significance of the programmed death ligand 1 expression in clear cell renal cell carcinoma and correlation with the tumor microenvironment and hypoxia-inducible factor expression.
    Tatli Dogan H; Kiran M; Bilgin B; Kiliçarslan A; Sendur MAN; Yalçin B; Ardiçoglu A; Atmaca AF; Gumuskaya B
    Diagn Pathol; 2018 Aug; 13(1):60. PubMed ID: 30144808
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bromodomain-containing protein 9 is a prognostic biomarker associated with immune infiltrates and promotes tumor malignancy through activating notch signaling pathway in negative HIF-2α clear cell renal cell carcinoma.
    Lou W; Gao K; Xu C; Li Q
    IUBMB Life; 2021 Nov; 73(11):1334-1347. PubMed ID: 34415102
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Factor-inhibiting hypoxia-inducible factor expression in patients with high-risk locally advanced renal cell carcinoma and its relationship with tumor progression.
    Deng S; Zhang P; Zeng H; Wang W; Jin T; Wang J; Dong Q
    Kaohsiung J Med Sci; 2014 Jan; 30(1):12-9. PubMed ID: 24388053
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mining tissue microarray data to uncover combinations of biomarker expression patterns that improve intermediate staging and grading of clear cell renal cell cancer.
    Dahinden C; Ingold B; Wild P; Boysen G; Luu VD; Montani M; Kristiansen G; Sulser T; Bühlmann P; Moch H; Schraml P
    Clin Cancer Res; 2010 Jan; 16(1):88-98. PubMed ID: 20028743
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypoxia-inducible factor-2alpha correlates to distant recurrence and poor outcome in invasive breast cancer.
    Helczynska K; Larsson AM; Holmquist Mengelbier L; Bridges E; Fredlund E; Borgquist S; Landberg G; Påhlman S; Jirström K
    Cancer Res; 2008 Nov; 68(22):9212-20. PubMed ID: 19010893
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combined over-expression of the hypoxia-inducible factor 2α gene and its long non-coding RNA predicts unfavorable prognosis of patients with osteosarcoma.
    Li W; He X; Xue R; Zhang Y; Zhang X; Lu J; Zhang Z; Xue L
    Pathol Res Pract; 2016 Oct; 212(10):861-866. PubMed ID: 27623205
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HIF-2alpha enhances beta-catenin/TCF-driven transcription by interacting with beta-catenin.
    Choi H; Chun YS; Kim TY; Park JW
    Cancer Res; 2010 Dec; 70(24):10101-11. PubMed ID: 21159632
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Decreased prolyl hydroxylase 3 mRNA expression in oncocytomas compared with clear cell renal cell carcinoma.
    Kampantais S; Kounatidis I; Kotoula V; Vakalopoulos I; Gkagkalidis K; Dimitriadis G
    Int J Biol Markers; 2020 Dec; 35(4):80-86. PubMed ID: 33118406
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumor VEGF expression correlates with tumor stage and identifies prognostically different groups in patients with clear cell renal cell carcinoma.
    Minardi D; Santoni M; Lucarini G; Mazzucchelli R; Burattini L; Conti A; Bianconi M; Scartozzi M; Milanese G; Primio RD; Montironi R; Cascinu S; Muzzonigro G
    Urol Oncol; 2015 Mar; 33(3):113.e1-7. PubMed ID: 25069421
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correlation between BOLD-MRI and HIF expression level in renal carcinoma.
    Li D; Wang X; Wang S; Cheng J
    Int J Clin Exp Pathol; 2015; 8(10):13759-63. PubMed ID: 26722605
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Notch1 predicts recurrence and survival of patients with clear-cell renal cell carcinoma after surgical resection.
    An H; Zhu Y; Xu L; Chen L; Lin Z; Xu J
    Urology; 2015 Feb; 85(2):483.e9-483.e14. PubMed ID: 25559729
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.